Form 4 for LUNG Pulmonx Corp
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $25.91 | -1,132 | 1.06M | -0.1% | -$29.3K |
| D | 2022-03-03 | 2022-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +69.7K | 1.13M | +7% | $0 |
| D | 2022-03-03 | 2022-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +154.6K | 154.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | S | D | 1,132 | $25.91 | 1,062,817 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 69,700 | $0.00 | 1,132,517 | D | — | — | (F2) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-03-01 | A | A | 154,600 | $0.00 | 154,600 | D | $26.56 · — to 2032-02-29 | 154,600 Common Stock | (F3) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022. |